NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation ...

Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities. Vector ...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and ...

Click Chemistry Tools produces click chemistry linkers and labeling reagents Fluoroprobes creates fluorescent probes and dyes Vector Laboratories manufactures proteomic and glycomic research products ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...

GTCR, a leading private equity firm, today announced that it has completed a strategic equity investment in Vector Laboratories, Inc. (“Vector” or the “Company”), through GTCR’s previously established ...

The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression The Glysite™ Explorer in situ PLA Glycan Detection Kit is a fully ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...

Vector Laboratories is a trusted reagent and critical component manufacturing partner, empowering biopharma, life science tools and diagnostics companies to accelerate their ability to provide value ...

Leader in manufacturing reagents and critical components for biomedical research to leverage Etcembly’s AI platform to optimize antibody engineering Under the agreement, Vector Laboratories will ...